p14-ARF transcription is stimulated by RUNX proteins

Stable Identifier
R-HSA-8952101
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Binding of the RUNX1:CBFB complex to the p14-ARF promoter at the CDKN2A locus promotes p14-ARF transcription (Linggi et al. 2002). The complex of acetylated RUNX3 and BRD2 positively regulates p14-ARF transcription, leading to activation of TP53 (p53) in response to oncogenic KRAS signaling. It is possible that RUNX3 directly binds to Runx response elements in the p14-ARF promoter that are recognized by RUNX1, although the direct association of RUNX3 with the CDKN2A gene has not been examined (Lee et al. 2013).

Literature References
PubMed ID Title Journal Year
12091906 The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia

Linggi, B, Müller-Tidow, C, van de Locht, L, Hu, M, Nip, J, Serve, H, Berdel, WE, van der Reijden, B, Quelle, DE, Rowley, JD, Cleveland, J, Jansen, JH, Pandolfi, PP, Hiebert, SW

Nat. Med. 2002
24229708 Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma

Lee, YS, Lee, JW, Jang, JW, Chi, XZ, Kim, JH, Li, YH, Kim, MK, Kim, DM, Choi, BS, Kim, EG, Chung, JH, Lee, OJ, Lee, YM, Suh, JW, Chuang, LS, Ito, Y, Bae, SC

Cancer Cell 2013
Participants
Participant Of
This event is regulated
Authored
Reviewed
Created